Your innovations should have a chance to make a difference
One barrier to the successful commercialization of innovations arising from Ontario’s life sciences sector is the scarcity of funding to advance breakthroughs with market potential. FACIT makes it possible for Ontario’s best cancer research discoveries to compete globally and reach patients.
Prospects Oncology Fund
FACIT’s Prospects Fund is designed to support early stage proof-of-concept (POC) studies within Ontario academic institutions and start-ups that fit with FACIT’s Ontario First investment strategy and have the potential to act as deal flow for the Compass Rose Fund. Prospects funding ranges between $50,000 and $200,000.
Compass Rose Oncology Fund
FACIT’s Compass Rose Fund helps Ontario’s cancer research innovators, arising from both public and private sectors, realize the commercial possibilities of their inventions by supporting early stage development projects. The Compass Rose Fund anchors and scales biotechs and attracts investment to Ontario, supporting the province’s competitive position as a destination for biotechnology.
Falcons’ Fortunes invites Ontario-based entrepreneurs working in the oncology space to pitch innovative research ideas to an external panel of judges.